Literature DB >> 22440866

Characteristics and treatment of seizures in patients with high-grade glioma: a review.

Dario J Englot1, Mitchel S Berger, Edward F Chang, Paul A Garcia.   

Abstract

High-grade gliomas (HGGs), including anaplastic astrocytoma and glioblastoma multiforme, are the most common primary brain tumors, and are often associated with seizures. Seizure control is a critical but often underappreciated goal in the treatment of patients harboring these malignant lesions. Patients with HGG who also have medically intractable seizures should be considered for a palliative resection guided by electrocorticography and functional mapping. Antiepileptic drugs remain the mainstay of seizure treatment in HGG, and antiepileptic medication should be started after a tumor-related seizure, but should not be used prophylactically in the absence of seizure activity. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22440866     DOI: 10.1016/j.nec.2012.01.009

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  23 in total

1.  Efficacy and safety of Levetiracetam vs. other antiepileptic drugs in Hispanic patients with glioblastoma.

Authors:  Andrés F Cardona; Leonardo Rojas; Beatriz Wills; Laura Bernal; Alejandro Ruiz-Patiño; Oscar Arrieta; Enrique Jiménez Hakim; Fernando Hakim; Juan Armando Mejía; Nicolás Useche; Sonia Bermúdez; Hernán Carranza; Carlos Vargas; Jorge Otero; Luis Carlos Mayor; León Darío Ortíz; Sandra Franco; Carlos Ortíz; Miguel Gil-Gil; Carmen Balaña; Zyanya Lucia Zatarain-Barrón
Journal:  J Neurooncol       Date:  2017-11-25       Impact factor: 4.130

2.  Family as the primary caregiver: palliative care in the Golan Heights.

Authors:  Elon Richman; Amit Ringel; Jonah Susser Kreniske; Wajdi Safadi
Journal:  BMJ Case Rep       Date:  2015-04-09

3.  Treatment of astrocytoma grade III with Photofrin II as a radiosensitizer. A case report.

Authors:  M Schaffer; A Hofstetter; B Ertl-Wagner; R Batash; J Pöschl; P M Schaffer
Journal:  Strahlenther Onkol       Date:  2013-10-26       Impact factor: 3.621

4.  Effects of salidroside on glioma formation and growth inhibition together with improvement of tumor microenvironment.

Authors:  Yanshan Zhang; Yunyi Yao; Huijuan Wang; Yanqin Guo; Hui Zhang; Liang Chen
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

5.  Overexpression of p53 delivered using recombinant NDV induces apoptosis in glioma cells by regulating the apoptotic signaling pathway.

Authors:  Xiaoyong Fan; Hongzhen Lu; Youqiang Cui; Xianzeng Hou; Chuanjiang Huang; Guangcun Liu
Journal:  Exp Ther Med       Date:  2018-03-08       Impact factor: 2.447

6.  β-catenin knockdown inhibits the proliferation of human glioma cells in vitro and in vivo.

Authors:  Zhong Wang; Qianxue Chen
Journal:  Exp Ther Med       Date:  2016-01-15       Impact factor: 2.447

7.  Efficacy of vagus nerve stimulation in brain tumor-associated intractable epilepsy and the importance of tumor stability.

Authors:  Kunal S Patel; Nelson Moussazadeh; Werner K Doyle; Douglas R Labar; Theodore H Schwartz
Journal:  J Neurosurg       Date:  2013-04-19       Impact factor: 5.115

Review 8.  Epilepsy and brain tumors.

Authors:  Dario J Englot; Edward F Chang; Charles J Vecht
Journal:  Handb Clin Neurol       Date:  2016

Review 9.  Rates and predictors of seizure freedom in resective epilepsy surgery: an update.

Authors:  Dario J Englot; Edward F Chang
Journal:  Neurosurg Rev       Date:  2014-02-05       Impact factor: 3.042

10.  Efficacy of vagus nerve stimulation as a treatment for medically intractable epilepsy in brain tumor patients. A case-controlled study using the VNS therapy Patient Outcome Registry.

Authors:  Kunal S Patel; Douglas R Labar; Charles M Gordon; Kevin H Hassnain; Theodore H Schwartz
Journal:  Seizure       Date:  2013-06-12       Impact factor: 3.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.